Citadel Advisors’s SOC Telemed, Inc. Class A Common Stock TLMD Stock Holding History

Citadel Advisors’s Portfolio TLMD Stock Details TLMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-70,360	Closed	-$253K	–	15160
2021 Q2	$400K	Sell	70,360 -115,646	-62%	-$769K	﹤0.01%	10564
2021 Q1	$1.17M	Buy	+186,006	New	+$1.4M	﹤0.01%	7709

Citadel Advisors's TLMD Position: Q3 2021 in Review

Citadel Advisors sold out of SOC Telemed, Inc. Class A Common Stock (TLMD) in Q3 2021, closing a stake of 70,360 shares — an estimated $253K sold.

Citadel Advisors first reported a position in TLMD in Q1 2021 and held it in 2 quarters. The position peaked at $1.17M in Q1 2021. 64 funds tracked by Wall St. Rank hold TLMD as of Q3 2021.

Citadel Advisors reported no remaining SOC Telemed, Inc. Class A Common Stock position as of Q3 2021 after selling out during the quarter.
Citadel Advisors sold 70,360 SOC Telemed, Inc. Class A Common Stock shares in Q3 2021, an estimated $253K.
Citadel Advisors first reported a position in SOC Telemed, Inc. Class A Common Stock in Q1 2021 and held it in 2 quarters.
Citadel Advisors's SOC Telemed, Inc. Class A Common Stock position peaked at $1.17M in Q1 2021.
64 funds tracked by Wall St. Rank held SOC Telemed, Inc. Class A Common Stock as of Q3 2021.

Based on Citadel Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.